13F Data
13F filer · CIK 1493215

RTW INVESTMENTS, LP

NEW YORK, NY · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$11.7B
+$1.7B vs prior
Positions
84
New / sold out
9 / 13
Added / reduced
26 / 8
Turnover
10.3%
buys $1.2B · sells $1.1B
Top-10 weight
47.7%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewKAILERA THERAPEUTICS INC+10,776,820–+$237.4M
AddedULTRAGENYX PHARMACEUTICAL IN+4,148,100+113.7%+$138.5M
AddedCG ONCOLOGY INC+1,529,782+21.9%+$108.7M
AddedORUKA THERAPEUTICS INC+1,080,882+52.5%+$102.9M
NewSTRUCTURE THERAPEUTICS INC+1,607,507–+$86.3M
AddedUNIQURE NV+1,355,216+52.4%+$62.4M
AddedIRHYTHM HOLDINGS INC+514,131+30.8%+$61.2M
NewAXOGEN INC+1,011,576–+$46.7M
NewDANAHER CORP DEL+230,000–+$43.8M
NewSOLID BIOSCIENCES INC+3,892,926–+$38.9M
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outAPOGEE THERAPEUTICS INC-2,782,097-100.0%$-234.2M
Sold outAPELLIS PHARMACEUTICALS INC-3,685,045-100.0%$-148.2M
ReducedCOGENT BIOSCIENCES INC-3,149,654-57.7%$-121.9M
ReducedHINGE HEALTH INC-1,430,000-74.1%$-118.7M
Sold outINTUITIVE SURGICAL INC-220,000-100.0%$-101.4M
Sold outCENTESSA PHARMACEUTICALS PLC-2,054,175-100.0%$-81.6M
ReducedNATERA INC-250,000-20.0%$-67.9M
Sold outCRINETICS PHARMACEUTICALS IN-1,451,326-100.0%$-52.7M
Sold outWAYSTAR HLDG CORP-1,630,000-100.0%$-39.3M
Sold outARROWHEAD PHARMACEUTICALS IN-585,682-100.0%$-36.7M
11 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $270.3MQ1 2015: $221.5MQ2 2015: $343.5MQ3 2015: $321.8MQ4 2015: $307.4MQ1 2016: $275.4MQ2 2016: $292.7MQ3 2016: $330.9MQ4 2016: $265.7MQ1 2017: $379.9MQ2 2017: $474.4MQ3 2017: $574.2MQ4 2017: $599.1MQ1 2018: $1.1BQ2 2018: $1.4BQ3 2018: $1.7BQ4 2018: $1.1BQ1 2019: $1.5BQ2 2019: $1.9BQ3 2019: $1.7BQ4 2019: $2.7BQ1 2020: $2.3BQ2 2020: $3.6BQ3 2020: $4.2BQ4 2020: $6.0BQ1 2021: $6.4BQ2 2021: $6.6BQ3 2021: $6.6BQ4 2021: $6.8BQ1 2022: $4.8BQ2 2022: $3.9BQ3 2022: $4.3BQ4 2022: $4.9BQ1 2023: $4.8BQ2 2023: $5.3BQ3 2023: $4.7BQ4 2023: $6.4BQ1 2024: $6.8BQ2 2024: $6.5BQ3 2024: $6.9BQ4 2024: $6.6BQ1 2025: $6.5BQ2 2025: $7.0BQ3 2025: $8.1BQ4 2025: $10.0BQ1 2026: $10.0BQ2 2026: $11.7B
Q4 2014Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1MADRIGAL PHARMACEUTICALS INCCOM1,993,687$1.1B9.14%
2ARGENX SESPONSORED ADR709,446$658.2M5.62%
3PTC THERAPEUTICS INCCOM7,746,415$631.9M5.39%
4PROTAGONIST THERAPEUTICS INCCOM5,061,175$620.4M5.30%
5CG ONCOLOGY INCCOM8,514,590$605.0M5.16%
6INSMED INCCOM PAR $.014,842,880$516.3M4.41%
7TANGO THERAPEUTICS INCCOM13,900,620$434.5M3.71%
8SPYRE THERAPEUTICS INCCOM NEW4,251,996$377.5M3.22%
9CELCUITY INCCOM3,304,903$345.8M2.95%
10ERASCA INCCOM17,946,754$328.8M2.81%
74 more rows. Subscribe for $29/month to see every row, download the data and use the API.